What is the recommended treatment regimen for uncomplicated and severe malaria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hospital Ward Malaria Treatment Prescription

For Uncomplicated Malaria (P. falciparum)

Artemether-Lumefantrine (Coartem) is the first-line treatment for uncomplicated malaria in hospitalized patients, with cure rates exceeding 95%. 1, 2

Standard Adult Regimen:

  • Artemether-Lumefantrine 20/120 mg tablets:
    • 4 tablets at hour 0
    • 4 tablets at hour 8 (same day)
    • 4 tablets twice daily (morning and evening) on days 2 and 3
    • MUST be taken with fatty food or milk (critical for absorption) 1, 2, 3

Alternative First-Line Option:

  • Dihydroartemisinin-Piperaquine:
    • 3 tablets daily for 3 days (for patients 36-75 kg)
    • 4 tablets daily for 3 days (for patients >75 kg)
    • Take on empty stomach 1, 2

Second-Line (if ACTs contraindicated):

  • Atovaquone-Proguanil (Malarone):

    • 4 tablets once daily for 3 days
    • Take with fatty meal 1
  • Quinine Sulfate 648 mg (two capsules) every 8 hours for 7 days PLUS Doxycycline 100 mg twice daily for 7 days (if patient ≥8 years old) 4, 5


For Severe Malaria

Intravenous Artesunate is the only acceptable first-line treatment for severe malaria, as delayed treatment significantly increases mortality. 1, 2, 3

IV Artesunate Regimen:

  • 2.4 mg/kg IV at 0,12, and 24 hours
  • Then 2.4 mg/kg IV once daily until parasitemia <1% and patient can tolerate oral medication 1, 2
  • Monitor parasitemia every 12 hours until <1%, then every 24 hours until negative 1, 3

Transition to Oral Therapy:

  • Once parasitemia <1% and patient tolerates oral intake: Complete full 3-day course of Artemether-Lumefantrine (as above) 1, 2

For Non-Falciparum Malaria (P. vivax, P. ovale, P. malariae)

In Chloroquine-Sensitive Regions:

  • Chloroquine:
    • 600 mg base at hour 0
    • 600 mg base at 24 hours
    • 300 mg base at 48 hours
    • (Total dose: 1,500 mg base over 3 days) 1, 2

Followed by Radical Cure (P. vivax/P. ovale only):

  • MUST test for G6PD deficiency first 2, 3
  • If G6PD normal: Primaquine 30 mg base daily for 14 days 2
  • If G6PD deficiency (30-70% activity): Primaquine 45 mg once weekly for 8 weeks 2

Special Populations

Pregnant Women:

  • Second and Third Trimester: Artemether-Lumefantrine (same dosing as above) 6, 1, 2
  • First Trimester (if no alternatives): Quinine 648 mg every 8 hours for 7 days PLUS Clindamycin 300 mg every 8 hours for 7 days 3

Renal Impairment (if using Quinine):

  • Loading dose: 648 mg once
  • Maintenance: 324 mg every 12 hours (starting 12 hours after loading dose) 4

Critical Monitoring Requirements

Post-Treatment Monitoring:

  • Check for post-artemisinin delayed hemolysis (PADH) on days 7,14,21, and 28 after treatment 1, 2, 3
  • Monitor hemoglobin/hematocrit at these intervals, as PADH occurs in 37.4% of patients 2

Drug Interactions and Contraindications:

  • Both Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine prolong QTc interval - avoid in patients with QTc prolongation risk or on QTc-prolonging medications 1, 2, 3
  • Primaquine and Tafenoquine are absolutely contraindicated in pregnancy 2

Common Pitfalls to Avoid

  • Failure to administer Artemether-Lumefantrine with fatty food results in subtherapeutic levels and treatment failure - this is the most common error 1, 2, 3
  • Do NOT give Dihydroartemisinin-Piperaquine with food - it must be taken fasting 1, 2
  • Never delay treatment while awaiting confirmatory testing in suspected severe malaria - mortality increases significantly with delays 1, 3
  • Always complete the full oral ACT course after IV artesunate, even if patient appears clinically well 1, 2

References

Guideline

Malaria Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Malaria Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Malaria Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of malaria in Thailand.

The Korean journal of parasitology, 2002

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.